IMAX delivered a quarter that surpassed Wall Street’s revenue and profit expectations, yet the market responded negatively. Management attributed the quarter’s performance to the global success of The Odyssey, which drove unprecedented demand for IMAX showings and enabled the company to achieve its highest-ever box office revenue. CEO Richard Gelfond highlighted that this surge in audience interest translated into a notable increase in system signings and a jump in operating margins, as moviegoers worldwide sought out the IMAX experience for major releases. CFO Natasha Fernandes emphasized the operating leverage in IMAX’s business model, explaining that higher box office results had a direct and disproportionate impact on profitability.

Is now the time to buy IMAX? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our top 5 analyst questions from IMAX’s Q3 earnings call

• Eric Handler (Roth Capital): asked if installation timelines could accelerate given strong demand and backlog. CEO Richard Gelfond explained that while some acceleration is possible, construction and permitting limits immediate impact for 2026 or 2027.
• Eric Wold (Texas Capital Securities): requested details on the pilot for smaller IMAX auditoriums and the addressable market. CFO Natasha Fernandes said these could enable entry into new urban markets while maintaining the IMAX experience, but specifics are still under evaluation.
• Drew Crum (B. Riley Securities): inquired about challenges and timing for expanding 70mm film locations. Gelfond indicated that technical innovation is enabling this, but precise rollout dates and costs are still being worked through.
• David Joyce (Seaport Research Partners): asked why system rental take rates declined year-on-year. Fernandes attributed this to film mix and local market factors but emphasized that overall flow-through and margins were at record highs due to The Odyssey’s performance.
• Omar Mejias (Wells Fargo): questioned whether dynamic pricing for peak showtimes is gaining traction. Gelfond stated that some exhibitors have started experimenting with higher pricing, and IMAX is encouraging broader adoption through data sharing.

Catalysts in upcoming quarters

In coming quarters, the StockStory team will be tracking (1) the pace of new system installations and signings, especially in underpenetrated markets; (2) the impact of upcoming blockbuster releases on box office and market share; and (3) the rollout and adoption of new auditorium formats and technology partnerships. We will also monitor whether merchandise and licensing contribute meaningfully to revenue diversification.

IMAX currently trades at $47.43, down from $51.76 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).

The best stocks for high-quality investors

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.